We previously demonstrated the induction of phospho-AKT with exposure to sotrastaurin in preclinical uveal melanoma models, suggesting upregulation of the PI3K/AKT pathway as a mechanism of resistance to PKC inhibition [13]. The gene discussed is AKT1; the disease is uveal melanoma.